Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ATLAS BIOGRAFERNE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.8% 2.8%   Bankruptcy risk   1.9% 1.2% 1.2% 3.9% 10.2% 4.6% 12.0% 11.7%   Credit score (0-100)   72 83 81 49 23 45 20 20   Credit rating   A A A BBB BB BBB BB BB   Credit limit (kDKK)   1.4 103.4 87.7 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,606 6,786 6,439 6,531 6,376 6,352 0.0 0.0   EBITDA   1,728 2,437 1,856 1,177 994 1,668 0.0 0.0   EBIT   446 977 431 -269 -843 -90.7 0.0 0.0   Pre-tax profit (PTP)   65.0 450.0 205.0 -431.0 -1,017.0 -363.0 0.0 0.0   Net earnings   47.0 348.0 156.0 -452.0 -783.0 -286.4 0.0 0.0   Pre-tax profit without non-rec. items   65.0 450 205 -431 -1,017 -363 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   8,650 7,837 7,026 6,619 6,553 7,695 0.0 0.0   Shareholders equity total   1,754 2,102 2,258 1,806 1,023 736 436 436   Interest-bearing liabilities   7,062 5,419 2,666 1,953 3,257 8,608 0.0 0.0   Balance sheet total (assets)   12,234 11,784 10,364 9,363 10,919 15,766 436 436   Net Debt   5,311 2,988 1,270 1,161 1,724 2,967 -436 -436     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,606 6,786 6,439 6,531 6,376 6,352 0.0 0.0   Gross profit growth   -5.7% 21.0% -5.1% 1.4% -2.4% -0.4% -100.0% 0.0%   Employees   12 13 13 12 12 9 0 0   Employee growth %   140.0% 8.3% 0.0% -7.7% 0.0% -25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,234 11,784 10,364 9,363 10,919 15,766 436 436   Balance sheet change%   13.2% -3.7% -12.1% -9.7% 16.6% 44.4% -97.2% 0.0%   Added value   1,728.0 2,437.0 1,856.0 1,177.0 603.0 1,668.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   726 -2,273 -2,236 -1,853 -1,903 -616 -7,695 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.0% 14.4% 6.7% -4.1% -13.2% -1.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.9% 8.1% 3.9% -2.7% -8.3% -0.6% 0.0% 0.0%   ROI %   5.6% 11.7% 5.8% -4.2% -16.5% -1.2% 0.0% 0.0%   ROE %   2.7% 18.0% 7.2% -22.2% -55.4% -32.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   14.3% 17.8% 21.8% 19.3% 9.4% 4.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   307.3% 122.6% 68.4% 98.6% 173.4% 177.9% 0.0% 0.0%   Gearing %   402.6% 257.8% 118.1% 108.1% 318.4% 1,168.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.2% 8.4% 5.6% 7.0% 6.7% 4.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.6 0.5 0.3 0.4 1.0 0.0 0.0   Current Ratio   0.6 0.6 0.5 0.4 0.6 1.2 0.0 0.0   Cash and cash equivalent   1,751.0 2,431.0 1,396.0 792.0 1,533.0 5,641.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,802.0 -1,704.0 -2,084.0 -2,977.0 -2,048.0 1,146.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   144 187 143 98 50 185 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   144 187 143 98 83 185 0 0   EBIT / employee   37 75 33 -22 -70 -10 0 0   Net earnings / employee   4 27 12 -38 -65 -32 0 0